ATE330597T1 - Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens - Google Patents

Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens

Info

Publication number
ATE330597T1
ATE330597T1 AT01955528T AT01955528T ATE330597T1 AT E330597 T1 ATE330597 T1 AT E330597T1 AT 01955528 T AT01955528 T AT 01955528T AT 01955528 T AT01955528 T AT 01955528T AT E330597 T1 ATE330597 T1 AT E330597T1
Authority
AT
Austria
Prior art keywords
fibrates
treatment
heart failure
congestive heart
production
Prior art date
Application number
AT01955528T
Other languages
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE330597T1 publication Critical patent/ATE330597T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01955528T 2000-08-01 2001-07-20 Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens ATE330597T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.

Publications (1)

Publication Number Publication Date
ATE330597T1 true ATE330597T1 (de) 2006-07-15

Family

ID=11454866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01955528T ATE330597T1 (de) 2000-08-01 2001-07-20 Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens

Country Status (18)

Country Link
US (2) US20030176499A1 (de)
EP (1) EP1305020B1 (de)
JP (1) JP2004505037A (de)
KR (1) KR100844190B1 (de)
CN (1) CN1798554A (de)
AT (1) ATE330597T1 (de)
AU (2) AU7768601A (de)
BR (1) BR0112874A (de)
CA (1) CA2415042C (de)
CY (1) CY1106318T1 (de)
DE (1) DE60120985T2 (de)
ES (1) ES2267796T3 (de)
IT (1) IT1317885B1 (de)
MX (1) MXPA03000900A (de)
PL (1) PL365040A1 (de)
PT (1) PT1305020E (de)
SK (1) SK287410B6 (de)
WO (1) WO2002009682A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481371A1 (en) * 2002-03-11 2003-09-18 Peter Zahradka Use of ppar alpha agonists for the treatment of vascular and renal diseases
CN100347262C (zh) * 2003-11-13 2007-11-07 同济大学 一种水溶性建筑粘结剂及其制备方法
JP5317919B2 (ja) * 2009-10-05 2013-10-16 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208203A1 (es) * 1974-09-10 1976-12-09 Cortial Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
AU4050797A (en) * 1996-08-02 1998-02-25 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
AU8182198A (en) * 1997-07-22 1999-02-16 Olin Corporation Copper alloy having magnesium addition
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0002667D0 (en) * 2000-02-04 2000-03-29 Glaxo Group Ltd medicamesnts
US7352911B2 (en) * 2003-07-31 2008-04-01 Hewlett-Packard Development Company, L.P. Method for bilateral filtering of digital images

Also Published As

Publication number Publication date
AU2001277686B2 (en) 2006-07-20
ES2267796T3 (es) 2007-03-16
EP1305020A2 (de) 2003-05-02
CA2415042A1 (en) 2002-02-07
ITRM20000433A0 (it) 2000-08-01
CY1106318T1 (el) 2011-10-12
SK1312003A3 (en) 2003-06-03
SK287410B6 (sk) 2010-09-07
WO2002009682A2 (en) 2002-02-07
WO2002009682A3 (en) 2002-04-18
PT1305020E (pt) 2006-10-31
CN1798554A (zh) 2006-07-05
ITRM20000433A1 (it) 2002-02-01
EP1305020B1 (de) 2006-06-21
DE60120985D1 (de) 2006-08-03
JP2004505037A (ja) 2004-02-19
CA2415042C (en) 2009-06-23
US20030176499A1 (en) 2003-09-18
KR20030041953A (ko) 2003-05-27
IT1317885B1 (it) 2003-07-15
US20090221701A1 (en) 2009-09-03
BR0112874A (pt) 2003-07-01
AU7768601A (en) 2002-02-13
KR100844190B1 (ko) 2008-07-04
MXPA03000900A (es) 2003-10-06
DE60120985T2 (de) 2006-12-21
PL365040A1 (en) 2004-12-27

Similar Documents

Publication Publication Date Title
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
NO972538D0 (no) Nye sulfonamider
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
DE69310065D1 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
EE200200333A (et) Fumaarhappe derivaatide kasutamine mitokondriaalsete haiguste raviks
ATE234615T1 (de) Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
SE8304003D0 (sv) Medicinsk komposition innehallande pirprofen
MY136269A (en) Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE360428T1 (de) Analgetisches arzneimittel
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE330597T1 (de) Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens
TW429146B (en) Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
AU6470400A (en) Nitroxy derivatives of (r) and (s)-carnitine
DE60122917D1 (de) Fermentative herstellung von d-p-hydroxyphenylglycin und d-phenylglycin
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
ATE445394T1 (de) Verwendung von citrullin zur herstellung eines arzneimittels zur behandlung von ans altern oder an eine bestrahlung gebundener intestinaler insuffizienz
ATE239492T1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
DE69610045D1 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
DE50012667D1 (de) Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von ischämischen zuständen
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305020

Country of ref document: EP

REN Ceased due to non-payment of the annual fee